Artesian VC
VC Fund
Melbourne, Australia
Artesian VC is a VC fund in Melbourne focused on Software and Artificial Intelligence. Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
- Total investments:
- 426
- Last investment:
- Lead investor:
- 35%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Artesian VC invests in
Stages Artesian VC invests in
Countries Artesian VC invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $101k–$5M
- Pre-Seed
- $70k–$1M
- Series A
- $2.3M–$15M
Investment Focus
Industry
- Software 34 (8%)
- Artificial Intelligence 28 (7%)
- Health Care 25 (6%)
- Information Technology 23 (5%)
- Agriculture 20 (5%)
Stage
- Seed 113 (27%)
- Series A 29 (7%)
- Pre-Seed 28 (7%)
- Funding Round 17 (4%)
- Series B 10 (2%)
Country
- Australia 92 (22%)
- United States 18 (4%)
- Hong Kong 12 (3%)
- China 11 (3%)
- India 11 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Luke Fay
Partner
|
Partner | Total investments: 5 | Find email | |
|
Matthew Clunies-Ross
Managing Partner
|
Managing Partner | Total investments: 3 | Find email | |
|
David Gallagher
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
David Rohrsheim
Portfolio Manager, South Australian Venture Capital Fund
|
Portfolio Manager, South Australian Venture Capital Fund | Total investments: 1 | Find email | |
|
Felix Zhang
Partner
|
Partner | Total investments: 2 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
BioScout utilises state-of-the-art technology to detect and prevent airborne diseases allowing for proactive disease management on farms worldwide! | $4.7M / Seed / Aug 07, 2026 | |
|
|
Matrix Origin is a leading technology provider of artificial intelligence, big data and cloud computing technology services in the industry. Our company has strong data-driven innovation ability in assisting enterprises to realize digital & intelligent transformation by providing low cost and high efficiency product and solution. Matrix Originhas the core data intelligence technology, advanced industry knowledge and rich program experience, which can quickly driving significant business value and laying the groundwork for digital transformation across the enterprise in different fields and industries.MatrixOne, developed by Matrix Origin, is a future-oriented hyper-converged cloud and edge native DBMS that supports transactional, analytical, and streaming workload with a simplified and distributed database engine, across multiple data centers, clouds, edges and other heterogeneous infrastructures.MatrixOne is bases on an open source project: https://github.com/matrixorigin/matrixone | $10M / Series A / Aug 06, 2026 | |
|
|
Juno Bio uses machine learning and state of the art bioinformatics to analyse and predict how best to manipulate microbiomes, significantly reducing the time and resources needed to improve their functionality. | $3.8M / Venture - Series Unknown / Jul 16, 2026 | |
|
|
Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges. | $7M / Seed / Mar 11, 2026 | |
|
|
Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries. | $21.3M / Series A / Mar 02, 2026 | |
|
|
CLIQ allows you to interact and connect with like-minded individuals and join interest-based clubs. | Venture - Series Unknown / Jan 05, 2026 | |
|
|
Ferronova is a medical device company that offers imaging and surgery products. | $6M / Series A / Dec 16, 2025 | |
|
|
MyGIG is an AI-powered Workforce Management Platform (WFM) and Employer Of Record (EOR), the first true Workforce-as-a-Service (WaaS). At MyGig, we’re redefining how businesses manage their contingent workforce. Whether you need on-demand staffing, payroll solutions, or end-to-end workforce management, MyGig simplifies the process—so you canfocus on growing your business.For Businesses: Reduce costs, streamline hiring, and ensure compliance with our smart workforce platform. We handle everything from sourcing and onboarding to managing time and attendance, timesheets, award interpretation, payroll, tax, and superannuation, so you don’t have to. Not mentioning Health & Safety, Workers Compensation and our new upcoming services such as Training and Benefits.For Workers: Find flexible positions that match your skills, preferences, and availability. Our intuitive mobile app connects you with shifts in real time, providing transparency on pay, scheduling, and career growth opportunities.Why MyGig? - AI-powered worker matching - Seamless payroll & compliance solutions (eg. Award interpretation) - Industry-specific workforce management - Data-driven insights for better workforce planningWe’re building the future of work—one shift at a time. Join us today! https://www.mygig.com.au/ | $653.6K / Pre-Seed / Nov 12, 2025 | |
|
|
Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology. | $10M / Seed / Nov 03, 2025 | |
|
|
SAMA Fertility is a virtual fertility clinic that offers fertility care and treatments, including preservation and evaluation services. | $3.8M / Seed / Jul 01, 2025 | |
| See all 426 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Artesian VC invest in?
Artesian VC invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 426 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Artesian VC's check size?
Artesian VC typically joins rounds of $101k–$5M at Seed, $70k–$1M at Pre-Seed and $2.3M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Artesian VC participates in.
How do I contact Artesian VC?
Public channels for Artesian VC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Artesian VC?
The team at Artesian VC includes Luke Fay (Partner), Matthew Clunies-Ross (Managing Partner) and David Gallagher (Managing Director), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!